|
cell cycle progression assessment method
|
BAO_0002047 |
|
|
M phase assessment method
|
BAO_0002741 |
|
|
EdU
|
BAO_0002742 |
|
|
deficiency anemia
|
DOID_13121 |
|
|
anemia
|
DOID_2355 |
|
|
protein-deficiency anemia
|
DOID_13120 |
|
|
hyperkalemic periodic paralysis
|
DOID_14451 |
|
|
familial periodic paralysis
|
DOID_1029 |
|
|
hypokalemic periodic paralysis
|
DOID_14452 |
|
|
farmer's lung
|
DOID_14453 |
|
|
extrinsic allergic alveolitis
|
DOID_841 |
|
|
fluorescent ligand binding method
|
BAO_0002755 |
|
|
second messenger
|
BAO_0002756 |
|
|
trifluoperazine
|
CHEBI_45951 |
|
|
Cyclic guanosine monophosphate
|
BAO_0002757 |
|
|
volume endpoint
|
BAO_0002758 |
|
|
prostate rhabdomyosarcoma
|
DOID_3252 |
|
|
prostate sarcoma
|
DOID_4054 |
|
|
benign meningioma
|
DOID_4587 |
|
|
central nervous system benign neoplasm
|
DOID_0060090 |
|
